Ambry Genetics announces GenomeNext whole-genome sequencing test
The company says the test solution is intended to improve diagnosis of rare diseases.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
For best results when printing this announcement, please click on link below: Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases New offering combines whole genome sequencing, RNA analysis and ongoing reanalysis to help address diagnostic challenges Ambr